Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liya Ding

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Plos Biology|July 4, 2018
CellProfiler 3.0: Next-generation image processing for biologyClaire McQuin, Allen Goodman, Vasiliy Chernyshev, et al.
Cancer Research|February 5, 2014
CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapyLiya Ding, Shuai Chen, Ping Liu, et al.
Nature Methods|November 13, 2025
Confocal Airy beam oblique light-sheet tomography for brain-wide cell type distribution and morphologyXiaoli Qi, Rodrigo Muñoz-Castañeda, Yuanlei Yue, et al.
Nature Methods|November 18, 2025
Author Correction: Confocal Airy beam oblique light-sheet tomography for brain-wide cell type distribution and morphologyXiaoli Qi, Rodrigo Muñoz-Castañeda, Yuanlei Yue, et al.
The EMBO Journal|February 7, 2019
EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasisYu Zhao, Liya Ding, Dejie Wang, et al.
Journal for Immunotherapy of Cancer|January 7, 2023
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancerLiya Ding, Qiwei Wang, Antons Martincuks, et al.
Science Advances|October 12, 2023
Whole human-brain mapping of single cortical neurons for profiling morphological diversity and stereotypyXiaofeng Han, Shuxia Guo, Nan Ji, et al.
Cell Reports|December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian CancerLiya Ding, Hye-Jung Kim, Qiwei Wang, et al.
Nature Communications|May 31, 2022
STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancerQiwei Wang, Johann S Bergholz, Liya Ding, et al.
Nature Immunology|May 20, 2026
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancerHan Dong, Arindam Ray, Lara K Rotter, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Plos Biology|July 4, 2018
CellProfiler 3.0: Next-generation image processing for biologyClaire McQuin, Allen Goodman, Vasiliy Chernyshev, et al.
Cancer Research|February 5, 2014
CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapyLiya Ding, Shuai Chen, Ping Liu, et al.
Nature Methods|November 13, 2025
Confocal Airy beam oblique light-sheet tomography for brain-wide cell type distribution and morphologyXiaoli Qi, Rodrigo Muñoz-Castañeda, Yuanlei Yue, et al.
Nature Methods|November 18, 2025
Author Correction: Confocal Airy beam oblique light-sheet tomography for brain-wide cell type distribution and morphologyXiaoli Qi, Rodrigo Muñoz-Castañeda, Yuanlei Yue, et al.
The EMBO Journal|February 7, 2019
EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasisYu Zhao, Liya Ding, Dejie Wang, et al.
Journal for Immunotherapy of Cancer|January 7, 2023
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancerLiya Ding, Qiwei Wang, Antons Martincuks, et al.
Science Advances|October 12, 2023
Whole human-brain mapping of single cortical neurons for profiling morphological diversity and stereotypyXiaofeng Han, Shuxia Guo, Nan Ji, et al.
Cell Reports|December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian CancerLiya Ding, Hye-Jung Kim, Qiwei Wang, et al.
Nature Communications|May 31, 2022
STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancerQiwei Wang, Johann S Bergholz, Liya Ding, et al.
Nature Immunology|May 20, 2026
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancerHan Dong, Arindam Ray, Lara K Rotter, et al.
Pageof 6